AU2004276307A1 - Novel triterpene derivatives, preparation thereof and use thereof - Google Patents

Novel triterpene derivatives, preparation thereof and use thereof Download PDF

Info

Publication number
AU2004276307A1
AU2004276307A1 AU2004276307A AU2004276307A AU2004276307A1 AU 2004276307 A1 AU2004276307 A1 AU 2004276307A1 AU 2004276307 A AU2004276307 A AU 2004276307A AU 2004276307 A AU2004276307 A AU 2004276307A AU 2004276307 A1 AU2004276307 A1 AU 2004276307A1
Authority
AU
Australia
Prior art keywords
compound
methyl
dimethylsuccinyl
hydrogen
pct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2004276307A
Other languages
English (en)
Inventor
Mark Ashton
Gary N. Robinson
Russell Thomas
Carl T. Wild
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Panacos Pharmaceuticals Inc
Original Assignee
Panacos Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacos Pharmaceuticals Inc filed Critical Panacos Pharmaceuticals Inc
Publication of AU2004276307A1 publication Critical patent/AU2004276307A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/708—Ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/34—Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/40—Succinic acid esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/34—Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/42—Glutaric acid esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/608—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a ring other than a six-membered aromatic ring in the acid moiety
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/52—Ortho- or ortho- and peri-condensed systems containing five condensed rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2004276307A 2003-09-26 2004-09-27 Novel triterpene derivatives, preparation thereof and use thereof Abandoned AU2004276307A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US50589903P 2003-09-26 2003-09-26
US60/505,899 2003-09-26
US55935804P 2004-04-05 2004-04-05
US60/559,358 2004-04-05
PCT/US2004/031370 WO2005030790A1 (en) 2003-09-26 2004-09-27 Novel triterpene derivatives, preparation thereof and use thereof

Publications (1)

Publication Number Publication Date
AU2004276307A1 true AU2004276307A1 (en) 2005-04-07

Family

ID=34396277

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2004276307A Abandoned AU2004276307A1 (en) 2003-09-26 2004-09-27 Novel triterpene derivatives, preparation thereof and use thereof

Country Status (10)

Country Link
US (1) US20050148561A1 (https=)
EP (1) EP1675866A1 (https=)
JP (1) JP2007506761A (https=)
KR (1) KR20060096147A (https=)
AU (1) AU2004276307A1 (https=)
BR (1) BRPI0415023A (https=)
CA (1) CA2540160A1 (https=)
IL (1) IL174317A0 (https=)
NO (1) NO20061792L (https=)
WO (1) WO2005030790A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1730163A4 (en) * 2004-03-17 2009-12-30 Panacos Pharmaceuticals Inc Pharmaceutical salts of 3-O- (3,3-dimethylsuccinyl) betulinic acid
EP1868613B1 (en) * 2005-04-12 2012-03-07 Myrexis, Inc. Polymorphs of 3-o-(3',3'-dimethylsuccinyl) betulinic acid di-n-methyl-d-glucamine
EP1893629A4 (en) * 2005-06-22 2008-12-17 Myriad Genetics Inc ANTIVIRAL CONNECTIONS
GB0604899D0 (en) * 2006-03-10 2006-04-19 York Pharma Plc Derivatives of 18-glycyrrhetinic acid
US20080039428A1 (en) * 2006-06-29 2008-02-14 Panacos Pharmaceuticals, Inc. Antiretroviral combination therapy
WO2008115281A2 (en) * 2006-10-16 2008-09-25 Myriad Genetics, Inc. Compounds for treating viral infections
AR063546A1 (es) 2006-11-03 2009-01-28 Panacos Pharmaceuticals Inc DERIVADOS DE TRITERPENO, METODOS PARA SU PREPARACION, COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN Y SU USO EN LA FABRICACION DE MEDICAMENTOS PARA EL TRATAMIENTO DE INFECCIoN POR EL VIRUS VIH.
WO2008146305A2 (en) * 2007-06-01 2008-12-04 Council Of Scientific & Industrial Research A pharmaceutical composition having virucidal and spermicidal activity
KR100941595B1 (ko) * 2008-06-05 2010-02-11 주식회사 알앤엘바이오 바이러스 억제제로서 유용한 트리테르페노이드계 화합물
CN102532245B (zh) * 2011-12-31 2013-05-15 中国人民解放军第三军医大学 一种熊果酸衍生物及其制备方法
EP3565527A4 (en) * 2017-01-05 2019-12-18 Regents of the University of California CONTRIBUTIVE USE OF TRITER PENOIDS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1415601A (en) * 1973-03-14 1975-11-26 Biorex Laboratories Ltd Dihydrobetulinic acid derivatives
AU2001294953A1 (en) * 2000-09-29 2002-04-08 Regents Of The University Of Minnesota Triterpenes having fungicidal activity against yeast

Also Published As

Publication number Publication date
KR20060096147A (ko) 2006-09-07
EP1675866A1 (en) 2006-07-05
BRPI0415023A (pt) 2006-11-07
US20050148561A1 (en) 2005-07-07
CA2540160A1 (en) 2005-04-07
IL174317A0 (en) 2006-08-01
WO2005030790A1 (en) 2005-04-07
NO20061792L (no) 2006-06-14
JP2007506761A (ja) 2007-03-22

Similar Documents

Publication Publication Date Title
US7365221B2 (en) Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof
EP1068219B1 (en) Acylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof
US20120214775A1 (en) Pharmaceutical Salts of 3-O-(3',3'-Dimethylsuccinyl) Betulinic Acid
CA2223513C (en) Betulinic acid derivatives and uses therefor
US20040131629A1 (en) Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof
AU2004276307A1 (en) Novel triterpene derivatives, preparation thereof and use thereof
US7799768B2 (en) Polymorphs of 3-O-(3′,3′-dimethylsuccinyl)betulinic acid di-N-methyl-D-glucamine
ZA200602758B (en) Novel triterpene derivatives, preparation thereof and use thereof
MXPA06003252A (en) Novel triterpene derivatives, preparation thereof and use thereof
ZA200608624B (en) Pharmaceutical salts of 3-0(3',3'-dimethylsuccinyl) betulinic acid
KR20070031888A (ko) ３－０－(３＇,３＇-다이메틸숙시닐)베툴린산의 약리학적염

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period